Drug search by name

Von Willebrand factor recombinant and Thromboembolic reactions

Result of checking the interaction of drug Von Willebrand factor recombinant and disease Thromboembolic reactions for safety when used together.

Check result:

Von Willebrand factor recombinant <> Thromboembolic reactions

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Thromboembolic reactions including disseminated intravascular coagulation (DIC), venous thrombosis, pulmonary embolism, myocardial infarction, and stroke can occur after therapy with von Willebrand factor, particularly in patients with risk factors for thrombosis. Monitor for early signs and symptoms of thrombosis such as pain, swelling, discoloration, dyspnea, cough, hemoptysis, and syncope and have prophylaxis measures against thromboembolism instituted according to current recommendations.

Von Willebrand factor recombinant

Generic Name: von willebrand factor

Brand Name: Vonvendi, Wilfactin

Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)

What is Von Willebrand factor recombinant?